Weight Loss Peptides Therapy Tirz CAS2023788-19-2 Liraglutide Semaglutide Lyophilized
2102 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
Tianjin
Tengchu
5 10 15 20 30 40 45mg*10vials
Yes
2026-06-30
ghk-cu,Semaglutide,tirzepatide,Retatrutide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
ghk-cu,Semaglutide,tirzepatide,Retatrutide
-
Location:
Room 68-5-501, Lianqiang Residential Area, No. 371 Union Road, Union Street, Xinhua District, Shijiazhuang City, Hebei Province
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
5 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2022
-
-
Inquiry History2102 Inquiries
Country Product Purchase Quantity Date Posted
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
United States
Tirzepatide
20 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Fip Cat Gs-441524 Fipv CAS 1191237-69-0 Treatment China Factory Supply
Top Grade / 99%
$2.5/UNIT FOB
-
-
-
-
Factory supply FOXO4 Peptide for Cosmetic
Chemical Grade / 99%
-
-
-
-
Cosmetic grade anti-aging FOXO4 cas2460055-10-9 High Purity for Raw Peptide Powder factory supply fast delivery
Cosmetics Grade / 99%
$28/UNIT FOB
-
-
-
-
High Purity powder CAS434-05-9 Body Building Peptide
Pharmaceutical Grade / 99%
-
-
-
-
High quality 139163-18-1 ellagic acid 4-O-xylopyranoside
Pharmaceutical Grade / 99%
-
-
-
-
TB500 peptide raw powder material
Cosmetics Grade / 99.9%
-